Back to homepage

Tag "children"

Transdermal buprenorphine for pain management in children

Authors: Giorgio Attinà, Alberto Romano, Silvia Triarico, Stefano Mastrangelo, Palma Maurizi, Antonio Ruggiero

This review aims to analyse the clinical advantages of transdermal buprenorphine in the paediatric population and the possible side effects registered in daily clinical practice.

More

Refractory symptoms in paediatric palliative care: can ketamine help?

Authors: Franca Benini, Sabrina Congedi, Luca Giacomelli, Simonetta Papa, Aashni Shah, Gregorio Milani

This narrative review analyses the use of ketamine in children and the potential extension of its applications in paediatric palliative care in order to provide new options for treatment in the paediatric palliative care setting.

More

Paediatrics: how to manage obstructive sleep apnoea syndrome

Authors: Theresa NH Leung, James WCH Cheng, Anthony KC Chan

This article provides a narrative review on the current diagnostic and treatment options for paediatric OSAS.

More

Novel therapeutic targets for allergic airway disease in children

Authors: Alessandro Giallongo MD, Giuseppe Fabio Parisi MD, Amelia Licari MD, Giulio Pulvirenti MD, Caterina Cuppari MD, Carmelo Salpietro MD, Gian Luigi Marseglia MD, Salvatore Leonardi MD

Keywords: allergic airway disease, allergic rhinitis, asthma, biologics, children, chronic rhinosinusitis, immunotherapy. Citation: Giallongo A, Parisi GF, Licari A, Pulvirenti G, Cuppari C, Salpietro C, Marseglia GL, Leonardia S. Novel therapeutic targets for allergic airway disease in children. Drugs in

More

Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland

Authors: George Kassianos, Sharon White, Arlene J Reynolds, Sankarasubramanian Rajaram

In 2012, the Joint Committee on Vaccination and Immunisation recommended that the UK National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2–17 years. The extension of this new immunisation programme began in 2013–2014 and targeted children aged 2–3 years in primary care. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children. In light of the lessons learnt from these pilot programmes, the authors make recommendations and offer practical advice to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries.

More